NB-4746 by Nura Bio for Amyotrophic Lateral Sclerosis: Likelihood of Approval
NB-4746 is under clinical development by Nura Bio and currently in Phase I for Amyotrophic Lateral Sclerosis. According to GlobalData,…
LGP5 LOA
-
-
ACTUS-101 by Asklepios BioPharmaceutical for Pompe Disease: Likelihood of Approval
ACTUS-101 is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Pompe Disease. According to GlobalData, Phase…
-
Gamma-PN by GPN Vaccines for Streptococcal Pneumonia: Likelihood of Approval
Gamma-PN is under clinical development by GPN Vaccines and currently in Phase II for Streptococcal Pneumonia. According to GlobalData, Phase…
-
Apraglutide by Ironwood Pharmaceuticals for Short Bowel Syndrome: Likelihood of Approval
Apraglutide is under clinical development by Ironwood Pharmaceuticals and currently in Phase III for Short Bowel Syndrome. According to GlobalData,…
-
AROC-3 by Arrowhead Pharmaceuticals for IgA Nephropathy (Berger’s Disease): Likelihood of Approval
AROC-3 is under clinical development by Arrowhead Pharmaceuticals and currently in Phase II for IgA Nephropathy (Berger's Disease). According to…
-
EXO-CD24 by Nano24med for Acute Respiratory Distress Syndrome: Likelihood of Approval
EXO-CD24 is under clinical development by Nano24med and currently in Phase II for Acute Respiratory Distress Syndrome. According to GlobalData,…
-
Fosravuconazole by Eisai for Tinea Pedis (Athlete Foot): Likelihood of Approval
Fosravuconazole is under clinical development by Eisai and currently in Phase II for Tinea Pedis (Athlete Foot). According to GlobalData,…
-
Dexamethasone sodium phosphate SR by Taiwan Liposome for Osteoarthritis Pain: Likelihood of Approval
Dexamethasone sodium phosphate SR is under clinical development by Taiwan Liposome and currently in Phase III for Osteoarthritis Pain. According…
-
Glufosfamide by Eleison Pharmaceuticals for Metastatic Adenocarcinoma of The Pancreas: Likelihood of Approval
Glufosfamide is under clinical development by Eleison Pharmaceuticals and currently in Phase III for Metastatic Adenocarcinoma of The Pancreas. According…
-
VMT-01 by Perspective Therapeutics for Metastatic Melanoma: Likelihood of Approval
VMT-01 is under clinical development by Perspective Therapeutics and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase…